Li Jin-Ze, Meng Shan-Shan, Xu Xiu-Ping, Huang Yong-Bo, Mao Pu, Li Yi-Min, Yang Yi, Qiu Hai-Bo, Pan Chun
Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
The State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease, Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Stem Cells Int. 2020 Oct 30;2020:8861407. doi: 10.1155/2020/8861407. eCollection 2020.
Mesenchymal stem cells (MSCs) may improve the treatment of acute respiratory distress syndrome (ARDS). However, few studies have investigated the effects of mechanically stretched -MSCs (MS-MSCs) in models of ARDS. The aim of this study was to evaluate the potential therapeutic effects of MS-MSCs on pulmonary microvascular endothelium barrier injuries induced by LPS. We introduced a cocultured model of pulmonary microvascular endothelial cell (EC) and MSC medium obtained from MSCs with or without mechanical stretch. We found that Wright-Giemsa staining revealed that MSC morphology changed significantly and cell plasma shrank separately after mechanical stretch. Cell proliferation of the MS-MSC groups was much lower than the untreated MSC group; expression of cell surface markers did not change significantly. Compared to the medium from untreated MSCs, inflammatory factors elevated statistically in the medium from MS-MSCs. Moreover, the paracellular permeability of endothelial cells treated with LPS was restored with a medium from MS-MSCs, while LPS-induced EC apoptosis decreased. In addition, protective effects on the remodeling of intercellular junctions were observed when compared to LPS-treated endothelial cells. These data demonstrated that the MS-MSC groups had potential therapeutic effects on the LPS-treated ECs; these results might be useful in the treatment of ARDS.
间充质干细胞(MSCs)可能会改善急性呼吸窘迫综合征(ARDS)的治疗效果。然而,很少有研究探讨机械拉伸的间充质干细胞(MS-MSCs)在ARDS模型中的作用。本研究旨在评估MS-MSCs对脂多糖(LPS)诱导的肺微血管内皮细胞屏障损伤的潜在治疗作用。我们建立了一种共培养模型,将肺微血管内皮细胞(EC)与从经过或未经过机械拉伸的间充质干细胞获得的培养基共同培养。我们发现,瑞氏-吉姆萨染色显示,机械拉伸后间充质干细胞的形态发生了显著变化,细胞质分别收缩。MS-MSCs组的细胞增殖远低于未处理的间充质干细胞组;细胞表面标志物的表达没有明显变化。与未处理的间充质干细胞的培养基相比,MS-MSCs的培养基中炎症因子在统计学上有所升高。此外,用MS-MSCs的培养基可恢复LPS处理的内皮细胞的细胞旁通透性,同时LPS诱导的内皮细胞凋亡减少。此外,与LPS处理的内皮细胞相比,观察到对细胞间连接重塑的保护作用。这些数据表明,MS-MSCs组对LPS处理的内皮细胞具有潜在的治疗作用;这些结果可能对ARDS的治疗有用。